The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
The re-emergence of the GP73 and fucosylated liver cancer biomarkers
Author(s): 
Pages: 59-64
Year: Issue:  4
Journal: Engineering Sciences

Keyword:  hepatocellular carcinomaGP73alpha fetoproteinfucosebiomarkers;
Abstract: The study shows that GP73 alone may not be sufficient to achieve the discrimination in every population. This is because many other clinical factors may influence the levels of the biomarker. This review attempts to identify some of these clinical variables,and helps provide a means of using these clinical values,in combination with GP73,to achieve the best use of the entire clinical biomarker family.
Related Articles
No related articles found